ACM
BIOA

Alessandra Capital Management’s BioAge Labs BIOA Stock Holding History

Alessandra Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Sell
93,368
-14,452
-13% -$261K 1.62% 15
2026
Q1 		$1.89M Sell
107,820
-27,840
-21% -$536K 1.61% 16
2025
Q4 		$1.79M Buy
+135,660
New +$1.2M 1.6% 16

Other funds holding BIOA

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Alessandra Capital Management's BIOA Position: Q2 2026 in Review

Alessandra Capital Management reduced its BioAge Labs (BIOA) stake by 13% in Q2 2026, selling an estimated $261K and leaving 93,368 shares worth $2.29M. The position accounts for 1.62% of the portfolio, ranked #15.

Alessandra Capital Management first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Alessandra Capital Management held 93,368 shares of BioAge Labs worth $2.29M as of Q2 2026.
  • Alessandra Capital Management sold 14,452 BioAge Labs shares in Q2 2026, an estimated $261K.
  • BioAge Labs made up 1.62% of Alessandra Capital Management's portfolio in Q2 2026, its #15 holding.
  • Alessandra Capital Management first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • 20 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Alessandra Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.